SecSonar.com

InterCure Ltd. (INCR)

InterCure Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

InterCure Ltd. (INCR) is a Drug Manufacturers - Specialty & Generic company based in IL with a market capitalization of $66.7M. Revenue grew 13.1% year-over-year and the company generated $4.4M in free cash flow. This page tracks INCR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IL · 320 employees · IPO Jan 28, 2019

Valuation

Valuation & price

$0.92 · as of May 26, 2026 · -46.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.69$1.21$0.73Jul 25Dec 25Jul 26Jul 7, 25$1.50Jul 9, 25$1.57Jul 11, 25$1.55Jul 15, 25$1.50Jul 17, 25$1.50Jul 21, 25$1.58Jul 23, 25$1.54Jul 25, 25$1.55Jul 29, 25$1.48Jul 31, 25$1.43Aug 4, 25$1.50Aug 6, 25$1.46Aug 11, 25$1.69Aug 13, 25$1.64Aug 15, 25$1.63Aug 19, 25$1.64Aug 21, 25$1.67Aug 25, 25$1.66Aug 27, 25$1.63Aug 29, 25$1.58Sep 3, 25$1.61Sep 5, 25$1.58Sep 9, 25$1.60Sep 11, 25$1.55Sep 16, 25$1.57Sep 18, 25$1.49Sep 22, 25$1.48Sep 24, 25$1.46Sep 26, 25$1.46Sep 30, 25$1.64Oct 2, 25$1.61Oct 6, 25$1.59Oct 8, 25$1.61Oct 10, 25$1.60Oct 14, 25$1.63Oct 16, 25$1.54Oct 21, 25$1.49Oct 23, 25$1.47Oct 27, 25$1.47Oct 29, 25$1.39Oct 31, 25$1.40Nov 4, 25$1.38Nov 6, 25$1.38Nov 10, 25$1.43Nov 12, 25$1.36Nov 14, 25$1.37Nov 18, 25$1.32Nov 20, 25$1.30Nov 25, 25$1.30Nov 28, 25$1.34Dec 2, 25$1.32Dec 4, 25$1.33Dec 8, 25$1.30Dec 10, 25$1.23Dec 12, 25$1.32Dec 16, 25$1.45Dec 18, 25$1.45Dec 22, 25$1.23Dec 24, 25$1.14Dec 29, 25$1.06Jan 2, 26$1.03Jan 6, 26$0.98Jan 8, 26$0.96Jan 12, 26$0.99Jan 14, 26$0.94Jan 16, 26$0.96Jan 21, 26$0.93Jan 23, 26$0.93Jan 27, 26$0.95Jan 29, 26$0.91Feb 2, 26$0.94Feb 4, 26$0.89Feb 9, 26$0.92Feb 11, 26$0.91Feb 13, 26$0.90Feb 18, 26$0.89Feb 20, 26$0.88Feb 24, 26$0.85Feb 26, 26$0.80Mar 2, 26$0.85Mar 4, 26$0.85Mar 6, 26$0.82Mar 10, 26$0.81Mar 12, 26$0.79Mar 17, 26$0.78Mar 19, 26$0.77Mar 23, 26$0.77Mar 25, 26$0.73Mar 27, 26$0.76Mar 31, 26$0.75Apr 2, 26$0.76Apr 7, 26$0.75Apr 9, 26$0.76Apr 13, 26$0.75Apr 15, 26$0.75Apr 17, 26$0.77Apr 22, 26$0.81Apr 24, 26$0.91Apr 28, 26$0.87Apr 30, 26$0.84May 4, 26$0.82May 6, 26$0.88May 8, 26$0.84May 12, 26$0.81May 14, 26$0.82May 18, 26$0.82May 20, 26$0.85May 22, 26$0.88May 28, 26$1.07Jun 1, 26$1.07Jun 3, 26$1.04Jun 5, 26$1.02Jun 9, 26$0.95Jun 11, 26$0.87Jun 15, 26$0.95Jun 17, 26$0.94Jun 22, 26$1.09Jun 24, 26$1.00Jun 26, 26$1.04Jul 2, 26$1.09
$0.7352-week range$1.73
Loading valuation history…

Fundamentals

Key fundamentals

$66.7M

Market cap

13.1%

Revenue growth (YoY)

12.3%

Gross margin

$4.4M

Free cash flow (USD)

$136.3M

Net debt

18.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$0.00FY 2019$8.9MFY 2020$65.0MFY 2021$219.7MFY 2022$388.7MFY 2023$355.6MFY 2024$238.8MFY 2025$270.2M
$0$270.2M

Free cash flow by year

2016 → 2025

FY 2016$-1.2MFY 2017$-921.0KFY 2018$-1.6MFY 2019$-4.0MFY 2020$-13.0MFY 2021$11.0MFY 2022$31.5MFY 2023$-56.3MFY 2024$-71.3MFY 2025$13.3M
-$1.2M$13.3M

Gross margin by year

2021 → 2025

FY 202141.5%FY 202239.9%FY 202329.6%FY 202412.7%FY 202512.3%
41.5%12.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed May 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingPrivate Placement FinancingJun 22, 2026Filing
  • 6-K filingStrategic Review and AcquisitionJun 15, 2026Filing
  • Annual reportAnnual Report FiledMay 1, 2026Filing
  • Annual report20-F FiledApr 30, 2026Filing

Questions

Frequently asked questions

What is InterCure Ltd.'s market cap?

InterCure Ltd. (INCR) has a market capitalization of $66.7M.

What is INCR's P/E ratio?

A meaningful P/E ratio is not available for INCR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying INCR stock?

SEC Form 4 filings show no open-market insider buys at InterCure Ltd. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

BGM

BGM Group Ltd.

$64.2M

IXHL

Incannex Healthcare Limited

$39.6M

ZYBT

Zhengye Biotechnology Holding Limited

$39.4M

CPIX

Cumberland Pharmaceuticals Inc.

$94.2M

SCYX

SCYNEXIS, Inc.

$37.7M

RMTI

Rockwell Medical, Inc.

$29.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.